Singapore Health Sciences Authority (HSA) approval marks the first in a series of expected approvals of Trodelvy in Asia
Everest Medicines a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products to address critical unmet needs in Asia Pacific markets, announced today that the Health Sciences Authority (HSA) of Singapore has approved Trodelvy
